TransiSoft®
Clinical Indication
Chronic constipation, use usually limited to 2 weeks
Comments
Not to be confused with other macrogol products such as Macrogol oral powder compound e.g. Laxido or Movicol
Date of classification
July 2022
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.